The largest peptide encyclopedia on the internet

FDA approves Onswik, a once-weekly basal insulin

Insulin efsitora alfa-gobe was approved for adults with type 2 diabetes; the label requires individualized dosing and strict prevention of hypoglycemia and dosing errors.